Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1982
12/08/1982EP0066296A2 Non-A, non-B hepatitis-associated antigen, a conjugate therof and diagnostic reagent containing same
12/07/1982US4362716 Dipeptides, their preparation and compositions containing them
12/07/1982US4362661 Immunoglobulin composition having a high monomer content, and process for production thereof
12/07/1982CA1137078A1 Modified grass pollen antigens
12/07/1982CA1136987A1 Double antibody reagent complex
12/01/1982EP0065924A1 DNA fragments carrying parts of the genetic information of polio viruses, namely of the PV 1 type, and process for their production
12/01/1982EP0065905A1 Stabilizing agents for live viruses for the preparation of vaccines, and stabilized vaccines containing these stabilizing agents
12/01/1982EP0065787A2 Immunopotentiator
11/1982
11/30/1982US4361550 Complement-fixing monoclonal antibody to human suppressor T cells and methods of preparing same
11/30/1982US4361549 Thymus cells; diagnosis and treatment of leukemia
11/30/1982US4361509 Ultrapurification of factor VIII using monoclonal antibodies
11/25/1982WO1982004067A1 Dna fragments carrying portions of genetic information of poliovirus, particularly of the pv1 type, and method for obtaining them
11/25/1982WO1982003988A1 Strongly antigenic tumor specific substances and methods for detecting cancer using said substances
11/24/1982EP0065320A1 Coupling process of a medicament to a thiolated polypeptidic compound coming from a fragment of the tetanic toxine, and its uses
11/24/1982EP0065286A2 Process for the purification or concentration of biologically active proteins, and appropriate means therefor
11/24/1982EP0065069A2 Latex for immobilizing biologically active substances
11/23/1982CA1136043A1 Vaccines against diseases, caused by reo-virus, and process for the preparation of those vaccines
11/23/1982CA1136042A1 Vaccine and method for prophylaxis and treatment of trichophytosis caused by pathogenic organism trichophyton mentagrophytes and method for preparing same
11/23/1982CA1136041A1 Propranolol antigen conjugates and antibodies
11/17/1982EP0064967A1 Process for producing submicroscopic particles, particles obtained in that way and pharmaceutical compositions containing them
11/16/1982CA1135643A1 Stabilization of pneumococcal polysaccharides
11/16/1982CA1135621A1 Hepatitis a virus cell culture in vitro
11/11/1982WO1982003872A1 B.thuringiensis crystal protein in e.coli
11/11/1982WO1982003871A1 Process for making novel blood clotting enzyme compositions
11/11/1982WO1982003769A1 Anthracycline glycoside compositions, their use and preparation
11/10/1982EP0064366A1 Pharmaceutical compositions
11/10/1982EP0064275A1 Immunochemical reagent
11/10/1982EP0064210A1 Oral pharmaceutical composition containing immune globulin
11/09/1982US4358604 N-Aminoalkyl iodothyronine derivatives
11/09/1982US4358438 Novel polyvalent virus vaccine against rabies and canine distemper
11/09/1982CA1135185A1 Agent for the therapy of immunocomplex diseases
11/03/1982EP0063988A1 Anticancer medicaments containing a ricin A-chain associated with an antimelanoma antibody, and process for their preparation
11/03/1982EP0063986A1 Process for detecting the presence of pneumococcal XIV antigens in a sample of human cells, and products for carrying out the process
11/03/1982EP0063953A2 Bacillus cloning vectors, recombinant DNA molecules, bacillus hosts transformed with them and methods for expressing foreign DNA sequences and producing polypeptides coded thereby
11/03/1982EP0063949A2 Plasmids coding for B. Thuringiensis crystal protein, their production and their use in creating genetically engineered bacterial strains, the aforesaid strains per se and their use in producing said protein, said protein so-produced, insecticidal formulations comprising the same and a method of producing an insecticidal effect
11/03/1982EP0063661A1 Process for inactivating foot-and-mouth disease virus (FMDV)
11/02/1982US4357421 Synthetic gene coding for influenza hemagglutinin
11/02/1982US4357320 Infectious bronchitis vaccine for poultry
11/02/1982US4357311 Substrate for immunoassay and means of preparing same
11/02/1982US4357273 Antitumor protein hybrid and process for the preparation thereof
11/02/1982US4357272 Recovering purified antibodies from egg yolk
11/02/1982US4357142 Absorption,bonding
11/02/1982CA1134766A1 Propagation of babesia parasites
10/1982
10/28/1982WO1982003632A1 cDNA REPRESENTING RNA VIRAL SEQUENCES
10/27/1982EP0063353A2 Highly purified messenger ribonucleic acid (m-RNA), process for preparing it and its use
10/26/1982US4356173 IgM Derivatives and process for the preparation thereof
10/26/1982US4356171 Novel glycoproteins
10/26/1982US4356170 Oxidation of vicinal hydroxy groups on polysaccharide, reductive amination with protein
10/26/1982US4356169 Extreaction with surfactant, then freeze drying
10/26/1982US4356164 Reacting with antibody followed by precipitation and measurement-screening blood donors
10/26/1982CA1134352A1 Ubiquitary tissue protein pp.sub.8
10/20/1982EP0063091A2 Mixtures of snake venoms for treatment of neurological and related disorders
10/20/1982EP0063064A1 Reagent for the radio-or enzymo-immunological determination of IgE
10/20/1982EP0062924A2 Protozoal antigen
10/20/1982EP0062892A1 Single incubation immunochemical assay for creatin phosphokinase MB
10/19/1982US4355019 Hepatitis A testing and growth in tree shrew as animal model
10/19/1982US4354967 Antigenic linear peptide compound
10/19/1982CA1133829A1 Pasteurellosis vaccines
10/14/1982WO1982003408A1 Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna-hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccins containing them
10/14/1982WO1982003330A1 Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnostic and pronostic of infections caused by the viruses of viral hepatitis
10/13/1982EP0062574A2 Virus protein synthesis
10/13/1982EP0062409A2 High fusion frequency fusible lymphoblastoid cell line
10/13/1982EP0062227A1 Artificial control and reference serum, method of making the same and its use
10/12/1982US4353822 Antigenic linear peptide compounds
10/06/1982EP0061974A2 New vaccine and therapy against non-A non-B viral hepatitis, and their preparation process
10/06/1982EP0061740A2 Process for the production of hybridisation probes
10/05/1982US4352884 Carrier having acrylate copolymer coating for immobilization of bioactive materials
10/05/1982US4352883 Encapsulation of biological material
09/1982
09/29/1982EP0061138A2 Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions
09/29/1982EP0060999A1 Galactopyranosides, process for their preparation and their use as antigens or immuno absorbents
09/28/1982US4351827 Novel polyvalent virus vaccine
09/28/1982US4351761 Purified antigen to test for Neisseria gonorrhoeae antibodies
09/22/1982EP0060499A2 Process for the preparation of a synthetic peptide for use as a vaccine, and vaccine containing it
09/22/1982EP0060491A2 Protein PP16, process for concentrating and isolating it, and its use
09/21/1982US4350686 Allergen composition and method for preparation thereof
09/21/1982US4350684 Veterinary medicine
09/21/1982US4350683 Antibody production from hybrid cell line
09/21/1982US4350626 Antitumor hybrid and process for the preparation thereof
09/21/1982US4350156 Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
09/21/1982CA1132047A1 Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component
09/16/1982WO1982003089A1 Monoclonal antibody
09/16/1982WO1982003088A1 Vaccines
09/16/1982WO1982003087A1 Selective genetic markers for eucaryotic cells,method for implementing such markers and application of cells containing such marker to the production of proteins determined after their transformation by a corresponding dna
09/16/1982WO1982003012A1 Method of obtaining of interferon and interferon in complex with antibacterial and antitoxic substances
09/15/1982EP0060129A2 Vaccines, a method for making vaccines and a method for stimulating antibody production
09/15/1982EP0060081A2 Piperazinoquinazoline antihypertensives, processes for preparing them, pharmaceutical compositions containing them, and immunogenic protein conjugates formed from them
09/14/1982US4349540 Process for preparing vaccines based on antigenic ribosomal fractions
09/14/1982US4349539 Separation of hepatitis B surface antigen
09/08/1982EP0059624A2 Isolation of principal outer membrane protein and antigen of chlamydia trachomatis
09/08/1982EP0059598A1 A process and apparatus for the recovery of immunoglobulines
09/08/1982EP0059563A2 An antigen drug and process of producing it for therapy of nonspecific allergic diseases
09/08/1982EP0059521A1 Water-in-oil emulsion for use in the potentation of the immune system of animals
09/07/1982US4348387 Method and system for the controlled release of biologically active substances to a body fluid
09/07/1982US4348316 New protein PP15, a process for its preparation and its use
09/07/1982CA1131130A1 Vaccine for equine rhinopneumonitis
09/02/1982WO1982002818A1 A process and apparatus for the recovery of immunoglobulins
08/1982
08/31/1982US4347239 Inactivated rabies vaccine for veterinary use
08/31/1982US4347138 Method of separating serum albumin and gamma-globulin from each other
08/31/1982CA1130726A1 Protection against dental caries
08/24/1982US4346074 Pasteurellosis vaccines
1 ... 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 ... 1823